[Federal Register: October 28, 2009 (Volume 74, Number 207)]
[Notices]
[Page 55611-55613]
[DOCID:fr28oc09-130]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-60857; File No. SR-CBOE-2009-074]

 Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Notice of Filing and Immediate Effectiveness of Proposed
Rule Change Amending Interpretation and Policy .13 to Rule 5.3

October 21, 2009.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on October 20, 2009, the Chicago Board Options Exchange, Incorporated
(``Exchange'' or ``CBOE'') filed with the Securities and Exchange
Commission (``Commission'') the proposed rule change as described in
Items I and II below, which Items have been prepared by the Exchange.
The Exchange filed the proposal as a ``non-controversial'' proposed
rule change pursuant to Section 19(b)(3)(A) of the Act \3\ and Rule
19b-4(f)(6) thereunder,\4\ which renders the proposal effective upon
filing with the Commission. The Commission is publishing this notice to
solicit comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A).
    \4\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    CBOE proposes to revise CBOE Rule 5.3.13(1)(E) to amend the
definition of Futures-Linked Securities for the trading of options on
Index-Linked Securities. The text of the rule proposal is available on
the Exchange's Web site (http://www.cboe.org/legal), at the Exchange's
Office of the Secretary and at the Commission.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    Interpretation and Policy .13 to Rule 5.3 designates the listing
and trading of options on ``Equity Index-Linked Securities,''
``Commodity-Linked Securities,'' ``Currency-Linked Securities,''
``Fixed Income Index-Linked Securities,'' ``Futures-Linked Securities''
and ``Multifactor Index-Linked Securities,'' collectively known as
``Index-Linked Securities'' that are principally traded on a national
securities exchange and an ``NMS Stock'' (as defined in Rule 600 of
Regulation NMS under the Securities and Exchange Act of 1934). The
Exchange proposes to amend the definition of Futures-Linked Securities
for the trading of options on Index-Linked Securities to include
products linked to CBOE Volatility Index (``VIX'') futures.
Specifically, the Exchange proposes to add VIX futures to the
definition of a Futures Reference Asset in Rule 5.3.13(1)(E).
    Index-Linked Securities are designed for investors who desire to
participate in a specific market segment by providing exposure to one
or more identifiable underlying securities, commodities, currencies,
derivative instruments or market indexes of the foregoing (``Underlying
Index'' or ``Underlying Indexes''). Index-Linked Securities are the
non-convertible debt of an issuer that have a term of at least one (1)
year but not greater than thirty (30) years. Despite the fact that
Index-Linked Securities are linked to an underlying index, each trade
as a single, exchange-listed security. Accordingly, rules pertaining to
the listing and trading of standard equity options apply to Index-
Linked Securities.
    Currently, the Exchange will consider listing and trading options
on Index-Linked Securities provided the Index-Linked Securities meet
the criteria for underlying securities set forth in Interpretation and
Policy .01 to Rule 5.3 or the criteria set forth in Interpretation and
Policy .13(3)(B) to Rule 5.3.
    Index-Linked Securities must meet the criteria and guidelines for
underlying securities set forth in Interpretation and Policy .01 Rule
5.3; or the Index-Linked Securities must be redeemable at the option of
the holder at least on a weekly basis through the issuer at a price
related to the applicable

underlying Reference Asset.\5\ In addition, the issuing company is
obligated to issue or repurchase the securities in aggregation units
for cash or cash equivalents satisfactory to the issuer of Index-Linked
Securities which underlie the option as described in the Index-Linked
Securities prospectus. Options on Index-Linked Securities will continue
to be subject to all Exchange rules governing the trading of equity
options. The current continuing or maintenance listing standards for
options traded on CBOE will continue to apply.
---------------------------------------------------------------------------

    \5\ See Interpretation and Policy .13(3)(B) to Rule 5.3. For the
purposes of Interpretation and Policy .13 to Rule 5.3, Equity
Reference Assets, Commodity Reference Assets, Currency Reference
Assets, Fixed Income Reference Assets, Futures Reference Assets and
Multifactor Reference Assets, are collectively referred to as
``Reference Assets.'' See Rule 5.3.13(2).
---------------------------------------------------------------------------

The VIX
    CBOE originally developed the VIX in 1993 and at that time the VIX
was calculated using S&P 100[supreg] Index options. CBOE introduced the
current methodology for the VIX in September 2003 and it is now an
index that uses the quotes of certain S&P 500[supreg] Index (``SPX'')
option series to derive a measure of the volatility of the U.S. equity
market. The VIX measures market expectations of near term volatility
conveyed by the prices of options on the SPX. It provides investors
with up-to-the-minute market estimates of expected stock market
volatility over the next 30 calendar days by extracting implied
volatilities from real-time index option bid/ask quotes.
VIX Futures
    The CBOE Futures Exchange (``CFE'') began listing and trading VIX
futures on March 26, 2004 under the ticker symbol VX. VIX Futures trade
between the hours of 8:30 a.m.-3:15 p.m. Central Time (Chicago Time).
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) \6\ of the Act, in general, and furthers the
objectives of Section 6(b)(5),\7\ in particular, in that it is designed
to prevent fraudulent and manipulative acts and practices, to promote
just and equitable principles of trade, to foster cooperation and
coordination with persons engaged in facilitating transactions in
securities, and to remove impediments to and perfect the mechanisms of
a free and open market and a national market system, and, in general,
to protect investors and the public interest. The Exchange believes
that the proposed rules applicable to trading pursuant to generic
listing and trading criteria, together with the Exchange's surveillance
procedures applicable to trading in the securities covered by the
proposed rules, serve to foster investor protection.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78f(b).
    \7\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    CBOE does not believe that the proposed rule change will impose any
burden on competition not necessary or appropriate in furtherance of
the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the proposed rule change does not: (i) Significantly affect
the protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative for 30
days after the date of filing (or such shorter time as the Commission
may designate if consistent with the protection of investors and the
public interest), the proposed rule change has become effective
pursuant to Section 19(b)(3)(A) of the Act \8\ and subparagraph (f)(6)
of Rule 19b-4 thereunder.\9\
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78s(b)(3)(A).
    \9\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)
requires a self-regulatory organization to provide the Commission
with written notice of its intent to file the proposed rule change,
along with a brief description and text of the proposed rule change,
at least five business days prior to the date of filing of the
proposed rule change, or such shorter time as designated by the
Commission. The Exchange has fulfilled this requirement.
---------------------------------------------------------------------------

    The Exchange has requested that the Commission waive the 30-day
operative delay and designate the proposed rule change as operative
upon filing. The Commission believes that waiving the 30-day operative
delay is consistent with the protection of investors and the public
interest. The proposed rule change is substantially similar to those of
other options exchanges that have been previously approved by the
Commission.\10\ Therefore, the Commission designates the proposal
operative upon filing to enable the Exchange to list and trade options
on index-linked securities without delay.\11\
---------------------------------------------------------------------------

    \10\ See Securities Exchange Act Release Nos. 60822 (October 14,
2009), 74 FR 54114 (October 21, 2009) (SR-NYSEArca-2009-77); and
60823 (October 14, 2009), 74 FR 54112 (October 21, 2009) (SR-
NYSEAmex-2009-59).
    \11\ For purposes only of waiving the operative delay of this
proposal, the Commission has considered the proposed rule's impact
on efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission may summarily abrogate such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in the furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-CBOE-2009-074 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-CBOE-2009-074. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/
sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for inspection and
copying in the Commission's Public Reference Room, 100 F Street, NE.,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of such filing also will be

available for inspection and copying at the principal office of the
Exchange. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
CBOE-2009-074 and should be submitted on or before November 18, 2009.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Elizabeth M. Murphy,
Secretary.
[FR Doc. E9-25830 Filed 10-27-09; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 88, Number 17 (Thursday, January 26, 2023)]
[Notices]
[Pages 5005-5007]
[FR Doc No: 2023-01551]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-0155]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Quantitative Research on Front of Package Labeling on
Packaged Foods

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing an
opportunity for public comment on a proposed collection of information.
Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are
required to publish notice in the Federal Register concerning each
proposed collection of information and to allow 60 days for public
comment in response to the notice. This notice invites comments on an
information collection associated with a study entitled ``Quantitative
Research on Front of Package Labeling on Packaged Foods.''

DATES: Either electronic or written comments on the collection of
information must be submitted by March 27, 2023.

ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of March 27, 2023. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are received on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2023-N-0155 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Quantitative Research on Front of
Package Labeling on Packaged Foods.'' Received comments, those filed in
a timely manner (see ADDRESSES), will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday,<PHONE_NUMBER>.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review
this copy, including the claimed confidential information, in our
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852,<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10 a.m.-12 p.m.,
11601 Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
[email protected].

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes requests or requirements that members of the
public submit reports, keep records, or provide information to a third
party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information before
submitting the collection to OMB for approval. To comply with this
requirement, FDA is publishing notice of the proposed collection of
information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Quantitative Research on Front of Package Labeling on Packaged Foods

OMB Control Number 0910-NEW

    The United States continues to face an epidemic of diet-related
chronic diseases, many of which are experienced disproportionately by
racial and ethnic minority groups, those with lower socioeconomic
status, and those living in rural areas.\1\ To help address this
problem, FDA has continued to prioritize its nutrition activities \2\
to help empower consumers with nutrition information to make healthier
choices more easily and encourage industry innovation by providing
flexibility to facilitate the production of healthier foods. FDA is
focused on: (1) creating a healthier food supply for all; (2)
establishing a healthy start to set the foundation for a long, healthy
life; and (3) empowering consumers through informative labeling and
tailored education.\3\
---------------------------------------------------------------------------

    \1\ https://www.cdc.gov/obesity/index.html.
    \2\ https://www.fda.gov/food/food-labeling-nutrition/fdas-nutrition-initiatives.
    \3\ https://www.whitehouse.gov/wp-content/uploads/2022/09/White-House-National-Strategy-on-Hunger-Nutrition-and-Health-FINAL.pdf.
---------------------------------------------------------------------------

    FDA is exploring the development of a front of package system to
help consumers interpret the nutrient information on food products.
Front of Package (FOP) labeling is intended to complement the Nutrition
Facts label by giving consumers a simple aid to provide additional
context for making healthy food selections. As part of our food-
labeling efforts, we are exploring the establishment of a standardized,
science-based FOP scheme that helps consumers, particularly those with
lower nutrition literacy, quickly and easily identify foods that are
part of a healthy eating pattern.
    The increased attention in recent years to FOP, and the experiences
of countries that have adopted FOP labeling suggests that FOP labeling
may aid nutrition comprehension and the ability to make healthier
choices, especially for those with lower nutrition literacy. FOP
schemes adopted in countries throughout the world include both
mandatory and voluntary labeling schemes and include non-
interpretative, interpretative, nutrient specific, and summary schemes.
    In 2022, FDA conducted a review of the literature on FOP nutrition-
related labels and conducted a set of focus groups to test FOP concepts
and draft FOP schemes (see Docket No. FDA-2023-N-0155 for the
literature review). These focus group results provided insights into
the varying ways that consumers interpret FOP nutrition information. As
part of our efforts to promote public health, we intend to conduct an
experimental study, informed by results of the focus group testing, to
further explore consumer responses to various FOP schemes. In the
experimental study, we will test a smaller subset of FOP schemes from
the

focus group testing, with additional variations informed by, among
other things, focus group results (see https://www.reginfo.gov/public/do/PRAViewIC?ref_nbr=202008-0910-021&icID=253321 for information about
FDA's front-of-pack focus groups, including graphic FOP schemes
tested). The study will be a controlled, randomized experiment that
will use a 15-minute web-based questionnaire to collect information
from 3,000 U.S. adult members of an online consumer panel maintained by
a contractor. The sample will be balanced to reflect the U.S. Census on
gender, education, age, and ethnicity/race. A measure of nutrition
literacy will also be used to balance the sample to ensure a variety of
literacy levels for each condition.
    Conditions for the study will be: (1) a set of draft FOP schemes,
including ``no-scheme'' controls; (2) three types of mock food products
(i.e., a breakfast cereal, a frozen meal, and a canned soup); and (3) a
``no-information'' condition where no explanation of the FOP scheme is
provided. Each participant will be randomly assigned to a condition,
which will include viewing a label image and responding to various
measures of the label's effectiveness. Some assignments may include
making a choice between two label images. Product perceptions (e.g.,
healthfulness and contribution to a healthy diet), label perceptions
(e.g., believability, trustworthiness, and effects perceptions), and
purchase/choice questions will constitute the measures of response in
the experiment. The instrument will also collect information from
participants about their history of purchasing or consuming similar
products, nutrition knowledge, dietary interests, motivation regarding
label use, health status, and demographic characteristics.
    The studies are part of our continuing effort to help enable
consumers to make informed dietary choices and construct healthful
diets. We intend to use the results to inform our continued exploration
of an FOP labeling scheme. We will not use the results to develop
population estimates.
    Description of Respondents: Respondents to this collection of
information include members of the general public.
    FDA estimates the burden of this collection of information as
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                  Number of
                   Activity                       Number of     responses per   Total annual          Average burden per response           Total hours
                                                 respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Experiment Pretest 1.........................             180               1             180  0.25 (15 minutes)........................              45
Experiment Pretest 2.........................              25               1              25  0.25 (15 minutes)........................               6
Experiment...................................           3,000               1           3,000  0.25 (15 minutes)........................             750
                                              ----------------------------------------------------------------------------------------------------------
    Total....................................  ..............  ..............  ..............  .........................................             801
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Dated: January 23, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-01551 Filed 1-25-23; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 87, Number 93 (Friday, May 13, 2022)]
[Notices]
[Page 29426]
[FR Doc No: 2022-10284]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Docket No. FAA-2022-0580]

Agency Information Collection Activities: Requests for Comments;
Clearance of Renewed Approval of Information Collection: Quality System
Audit Feedback Report

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FAA
invites public comments about its intention to request the Office of
Management and Budget (OMB) approval to renew an information
collection. The information is collected from FAA production approval
holders and associated facilities in the form of a feedback survey
regarding the conduct of the Quality System Audit (QSA) recently
conducted at their facility. The feedback is used by the FAA for
continuous quality improvement of the Aircraft Certification Service's
certificate management program.

DATES: Written comments should be submitted by July 12, 2022.

ADDRESSES: Please send written comments:
    By Electronic Docket: www.regulations.gov (Enter docket number into
search field).
    By Mail: Scott Geddie, Manager--Compliance Systems, AIR-634,
Aircraft Certification Service, Federal Aviation Administration, 6500
S. MacArthur Blvd., ARB Building Room 304, Oklahoma City, OK 73169.

FOR FURTHER INFORMATION CONTACT: Scott Geddie by email at:
[email protected]; phone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) whether the proposed
collection of information is necessary for FAA's performance; (b) the
accuracy of the estimated burden; (c) ways for FAA to enhance the
quality, utility, and clarity of the information collection; and (d)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize and/or include
your comments in the request for OMB's clearance of this information
collection.
    OMB Control Number: 2120-0605.
    Title: Quality System Audit Feedback Report.
    Form Numbers: FAA Form 8100-7.
    Type of Review: Renewal of an information collection.
    Background: In accordance with Executive Orders 12862 and 14058,
and as part of the FAA and industry continuous improvement efforts for
QSA activities, FAA utilizes a form for auditees to provide feedback to
the FAA about the conduct of the QSA. FAA Order 8120.23, Certificate
Management of Production Approval Holders, provides guidance on the QSA
and related activities and discusses FAA Form 8100-7, QSA Customer
Feedback Report. The FAA provides FAA Form 8100-7 to the facility being
audited at the outset of the QSA. The FAA encourages completion of the
form within 30 days of the QSA post-audit conference; however,
completion of the form is not mandatory. The FAA considers any
proposals for improvements to the QSA process in its pursuit for
continuous improvement of the Aircraft Certification Service's
certificate management of production approval holders. The form is
collected electronically or via prepaid self-addressed envelope.
    Respondents: Approximately 160 production approval holders and
associated facilities.
    Frequency: Feedback information is collected about 30 days after
conclusion of the oversight activity. The feedback provided is
voluntarily submitted by the audited facility on occasion which is
predicated on their audit due date frequency.
    Estimated Average Burden per Response: 30 minutes.
    Estimated Total Annual Burden: 80 hours.

    Issued in Oklahoma City, Oklahoma, on May 9, 2022.
Scott A. Geddie,
Manager, Compliance Systems, Systems Policy Branch, AIR-630, Policy and
Innovation Division.
[FR Doc. 2022-10284 Filed 5-12-22; 8:45 am]
BILLING CODE 4910-13-P


UNITED STATES ENVIRONMENTAL PROTECTION AGENCY Washington, D. C. 20460 Office of Prevention, Pesticides and Toxic Substances September 12, 2005 Susan A. Lewis, Ph. D. Methyl Bromide Industry Panel 1300 Wilson Boulevard Arlington, VA 22209 Re: Methyl Bromide: July 13, 2005 Notice of Availability and Opening of Comment Period for Preliminary Risk Assessments  70 Fed. Reg. 40336 Dear Dr. Lewis:

I am responding to your August 31 letter written on behalf of the Methyl Bromide Industry Panel ( MBIP). In your letter, you request an extension of the current comment period; ask that additional information be made publicly available in a legible format; and, seek clarification on how calculations were done in the assessment. Let me respond to each of your requests.

First, a Federal Register Notice was published today announcing the extension of the comment period for an additional 30 days. We request that you provide your comments no later than October 12, 2005.

Second, all illegible appendices in the e docket have been replaced in the e docket with legible copies for public comment. In addition, we are placing in the paper docket hard copies of the data cited in your letter that underlie the occupational risk assessment that were used to derive the material already summarized in Appendix T. These are the studies largely conducted by California that you reference in your letter. However, please note that public access to some of these data developed by industry may be statutorily limited by FIFRA section 10. Since the key results were already in Appendix T, we did not make this underlying information publicly available earlier, but are doing so now to increase the transparency of our calculations. Unfortunately, the Agency does not have the information in a format that would enable it to be posted in a legible format on the web. Third, we are correcting a small error in the spread sheets that involve the MOE calculations in Tables 6 and 20. We are going to post the revised information and will send you a copy shortly. I can ensure you that the MOE calculations were done consistent with EPA policy.

I hope the additional information we are providing is helpful, and we look forward to receiving your comments next month. I also wanted to let you know that we have a new Chemical Review Manager on Methyl Bromide, Steve Weiss. Steve has substantial experience in the occupational and residential risk assessment field. He can be reached on ( 703) 308 8293. Sue Bartow will continue to be involved in the project over the next month as Steve assumes his new duties.

Sincerely,

Debra Edwards, Ph. D. Director Special Review and Reregistration Division Office of Pesticide Programs/ USEPA cc: Sue Bartow Steve Weiss John Leahy Jeff Dawson